Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.39 |
| ▸ | HTR7 | P34969 | 3/20 | 0.35 |
| ▸ | HTR2B | P41595 | 3/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20032518 | 1.00 | PDK2 (0.39) | PDK2HTR7HTR2BAPEX1POLB | |
| SCHEMBL18235843 | 1.00 | PDK2 (0.39) | PDK2HTR7HTR2BAPEX1POLB | |
| SCHEMBL18012814 | 0.94 | MAPT (0.38) | PDK2HTR7HTR2BPOLBMAPT | |
| SCHEMBL20032407 | 0.92 | PDK2 (0.38) | PDK2HTR7HTR2BAPEX1POLB | |
| SCHEMBL18235845 | 0.91 | PDK2 (0.38) | PDK2HTR7HTR2BAPEX1POLB | |
| SCHEMBL20032516 | 0.91 | PDK2 (0.38) | PDK2HTR7HTR2BAPEX1POLB | |
| SCHEMBL18122995 | 0.91 | APEX1 (0.38) | PDK2HTR7HTR2BAPEX1POLB | |
| SCHEMBL28162990 | 0.90 | KMT2A (0.42) | PDK2MAPTSMN1; SMN2KMT2AL3MBTL1 | |
| SCHEMBL18012754 | 0.89 | PDK2 (0.38) | PDK2HTR7HTR2BAPEX1 | |
| SCHEMBL18235862 | 0.89 | PDK2 (0.36) | PDK2HTR7HTR2BAPEX1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3095778-B1 | OXIME ESTER FLUORENE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING IT, PHOTORESIST COMPOSITION, USES OF THE PHOTORESIST COMPOSITION | SAMYANG CORP (KR) | 2020-12-16 | — | — | EP | disclosed |
| US-9873663-B2 | Fluorenyl β-oxime ester compounds, photopolymerization initiator and photoresist composition containing the same | SAMYANG CORPORATION (KR) | 2018-01-23 | — | — | US | disclosed |
| EP-3095778-A1 | NOVEL -OXIMESTER FLUORENE COMPOUND, A PHOTOPOLYMERIZATION INITIATOR COMPRISING SAME, AND PHOTORESIST COMPOSITION | Samyang Corporation (KR) | 2016-11-23 | — | — | EP | disclosed |
| US-20160332960-A1 | NOVEL FLUORENYL B-OXIME ESTER COMPOUNDS, PHOTOPOLYMERIZATION INITIATOR AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SAMYANG CORPORATION (KR) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160332960-A1 | NOVEL FLUORENYL B-OXIME ESTER COMPOUNDS, PHOTOPOLYMERIZATION INITIATOR AND PHOTORESIST COMPOSITION CONTAINING THE SAME | PPOX, FTO, PFAS | PDK2 981/4885HTR7 3122/4885HTR2B 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.